Global Controlled Substances Market Growth (Status and Outlook) 2023-2029

Global Controlled Substances Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “Controlled Substances Industry Forecast” looks at past sales and reviews total world Controlled Substances sales in 2022, providing a comprehensive analysis by region and market sector of projected Controlled Substances sales for 2023 through 2029. With Controlled Substances sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Controlled Substances industry.

This Insight Report provides a comprehensive analysis of the global Controlled Substances landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Controlled Substances portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Controlled Substances market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Controlled Substances and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Controlled Substances.

The global Controlled Substances market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

North America has traditionally been the most lucrative market for controlled substances, with sales estimated to record a Y-o-Y of 5.0% in 2019 over 2018. This can be attributes in part to legalization of various forms of marijuana in the US, along with the recent approval of recreational marijuana sales in Canada.

This report presents a comprehensive overview, market shares, and growth opportunities of Controlled Substances market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Opioids
Stimulants
Depressants
Marijuana
Others

Segmentation by application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Johnson & Johnson
Pfizer
Siegfried AG
GlaxoSmithKline
Teva Pharmaceuticals
Mylan
Takeda Pharmaceutical
Sun Pharmaceutical
Daiichi Sankyo
Akorn Inc
Tilray
Medical Marijuana, Inc
Consort Medical
Purdue Pharma

Please note: The report will take approximately 2 business days to prepare and deliver.